Autologous
Matrix-induced Chondrogenesis Market, by Material Type (Collagen,
Polyethylene Glycol, Polylactic-Co-Glycolic Acid, and Hyaluronic Acid), by
Application (Knee Cartilage, Elbow Cartilage, and Hip Cartilage), by Region
(North America, Latin America, Europe, Asia Pacific, Middle East, And Africa) -
Size, Share, Outlook, and Opportunity Analysis, 2019-2027
Autologous matrix-induced
chondrogenesis is an innovative treatment to repair articular cartilage damage.
It is a one step process that uses the microfracturing method, which is
followed by application of bilayer collagen I/III membrane by partially
autologous fibrin glue. Increasing prevalence of bone and joint disorders such
as osteoporosis and arthritis, increasing sports-related injuries, and rising
demand for minimally-invasive surgery is driving the autologous matrix-induced
chondrogenesis market growth.
Autologous Matrix-induced Chondrogenesis
Market - Drivers
Increasing number of joint and
bone disorders such as osteoporosis and arthritis globally is expected to drive
the autologous matrix-induced chondrogenesis market growth during the forecast
period.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/2748
For instance, according to the
National Center for Biotechnology Information (NCBI) 2016 report, over 200
million people are suffering from osteoporosis worldwide in 2015. 1 in 3 women
over the age of 50 years and 1 in 5 men will experience osteoporosis fractures
in their lifetime.
Rising number of surgeries is
expected to drive the autologous matrix-induced chondrogenesis market growth
during the forecast period. For instance, according to American Academy of
Orthopaedic Surgeon (AAOS) 2019 report, around 267,000 knee replacements are performed
each year in the U.S.
Autologous Matrix-induced Chondrogenesis
Market - Restraints
Inefficient system of
reimbursement and high cost of cartilage replacement are major factors
restraining growth of the autologous matrix-induced chondrogenesis market.
Several health insurance companies do not insure AMIC procedure. For instance,
according to Blue Cross Blue Shield of North Carolina 2019, for patients
without health insurance, a total hip replacement usually costs between US$
31,839 and US$ 44,816, with an average cost of US$ 39,299 in the U.S.
Browse Research
Report: https://www.coherentmarketinsights.com/ongoing-insight/autologous-matrix-induced-chondrogenesis-market-2748
Autologous Matrix-induced
Chondrogenesis Market - Regional Analysis
On the basis of region, the
autologous matrix-induced chondrogenesis market is segmented into North
America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North
America is expected to hold dominant position in the autologous matrix-induced chondrogenesis
market during the forecast period, owing to increasing sports-related injuries
and rising population. For instance, according to National Safety Council (NSC)
report, in 2017, over 526,000 sports-related injuries were reported in the U.S.
Asia Pacific is expected to
witness significant growth over the forecast period, owing to rising demand for
minimally-invasive surgery in the region. For instance, according to the
National Center for Biotechnology Information, in 2017, minimally-invasive surgery
was carried out firstly in China. Laparoscopy surgery was one of the first
types of minimally-invasive surgery.
Autologous Matrix-induced
Chondrogenesis Market - Competitive Landscape
Key players operating in the
autologous matrix-induced chondrogenesis market include Biotissue AG,
Arthro-Kinetics, JRL Orthopaedic Ltd, B Braun, Melsungen AG, Matricel GmbH,
Geistlich Pharma AG, and Zimmer Biomet Holdings.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/2748
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and
competitive analysis through various recommendations related to emerging market
trends, technologies, and potential absolute dollar opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
No comments:
Post a Comment